Amelioration of autoimmune arthritis by naringin through modulation of T regulatory cells and Th1/Th2 cytokines

Cellular Immunology

Volumn 287, Issue 2, 2014, Pages 112-120

  Ahmad, Sheikh Fayaz ^a   Zoheir, Khairy M A ^a,d   Abdel Hamied, Hala E ^b   Ashour, Abdelkader E ^a   Bakheet, Saleh A ^a   Attia, Sabry M ^a,c   Abd Allah, Adel R A ^a,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b AL AZHAR UNIVERSITY   (Egypt)

^c Al Azhar University   (Egypt)

^d NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Adjuvant induced arthritis; Inflammatory mediators; Mouse model; Naringin; T cell subsets; Treg cells

Indexed keywords

AURANTIIN; CYTOKINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3;

ADJUVANT ARTHRITIS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOMODULATION; JOINT CAVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; TREATMENT DURATION; UPREGULATION;

ADJUVANT INDUCED ARTHRITIS; INFLAMMATORY MEDIATORS; MOUSE MODEL; NARINGIN; T CELL SUBSETS; TREG CELLS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD4; ARTHRITIS; AUTOIMMUNE DISEASES; CELLS, CULTURED; CITRUS PARADISI; CYTOKINES; DISEASE PROGRESSION; FEMALE; FLAVANONES; FORKHEAD TRANSCRIPTION FACTORS; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; INFLAMMATION MEDIATORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH1-TH2 BALANCE;

EID: 84893387292     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.01.001     Document Type: Article

References (53)

1. Glässer G., Graefe E.U., Struck F., Veit M., Gebhardt R. Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolites. Phytomedicine 2002, 9(1):33-40.
2. Maksimović Z., Malencić D., Kovacević N. Polyphenol contents and antioxidant activity of Maydis stigma extracts. Bioresour. Technol. 2005, 96(8):873-877.
3. Sekar T., Francis K.A. Preliminary investigation of some Maruthamalai forest plants for phytochemical compounds Source. Bioresour. Technol. 1999, 70(3):303-304.
4. Khatib A., Kim M.Y., Chung S.K. Anti-inflammatory activities of Cinnamomum burmanni Bl. Food Sci. Biotechnol. 2005, 14:223-227.
5. So F.V., Guthrie N., Chambers A.F. Inhibition of human breast cancer cell proliferation and delay ofmammary tumorigenesis by flavonoids and citrus juices. Nutr. Cancer 1996, 26:167-181.
6. Jeon S.M., Park Y.B., Choi M.S. Antihypercholesterolaemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. Clin. Nutr. 2004, 23:1025-1034.
7. Rajadurai M., Stanely P., Prince M. Naringin ameliorates mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol-induced myocardial infarction in Wistar rats. Phytother. Res. 2009, 23:358-362.
8. Choe S.C., Kim H.S., Jeong T.S., Bok S.H., Park Y.B. Naringin has an anti-atherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 2001, 38:947-955.
9. Jagetia G.C., Venkatesha V.A., Tiyyagura K.R. Naringin, a citrus flavonone, protects against radiation-induced chromosome damage in mouse bone marrow. Mutagenesis 2003, 18:337-343.
10. Jagetia G.C., Reddy T.K. Modulation of radiation induced alteration in the antioxidant status of mice by naringin. Life Sci. 2005, 77:780-794.
11. Ribeiro M., Barateiro A., Vila-Real H., Fernandes A., Brites D. Anti-inflammatory effect of naringin and naringenin on TNF-α secretion in cultured cortical astrocytes after stimulation with LPS. New Biotechnol. 2009, 25:S10-S11.
12. Amaro M.I., Rocha J., Vila-Real H., Eduardo-Figueira M., Mota-Filipe H., Sepodes B., Ribeiro M.H. Anti-inflammatory activity of naringin and the biosynthesized naringenin by naringinase immobilized in micro structured materials in a model of DSS-induced colitis in mice. Food Res. Int. 2009, 42:1010-1017.
13. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89:587-596.
14. Lee D.M., Weinblatt M.E. Rheumatoid arthritis. Lancet 2001, 358:903-911.
15. Verhoef C. T1/T2 cell balance in rheumatoid arthritis. Clin. Appl. Immunol. Rev. 2001, 1:153-161.
16. Fournier C. Where do T cells stand in rheumatoid arthritis?. Joint Bone Spine 2005, 72:527-532.
17. Skapenko A., Leipe J., Lipsky P.E., Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Res. Ther. 2005, 7(Suppl 2):S4-S14.
18. Shahrara S., Huang Q., Mandelin A.M., Pope R.M. Th-17 cells inrheumatoid arthritis. Arthritis Res. Ther. 2008, 10:R93.
19. Bryl E., Daca A., Jóźwik A., Witkowski J.M. Human CD4(low) CD25(high) regulatory T cells indiscriminately kill autologous activated T cells. Immunology 2009, 128(1 Suppl):287-295.
20. Schulze-Koops H., Kalden J.R. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 2001, 15:677-691.
21. Raziuddin S., Bahabri S., Al-Dalaan A., Siraj A.K., Al-Sedairy S. A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: immunoregulatory IL-10 function. Clin. Immunol. Immunopathol. 1998, 86:192-198.
22. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 2007, 148:32-46.
23. Niu Q., Huang B., Cai Z.C., Wang L.L., Feng W.H. Study on ratio imbalance of peripheral blood Th17/Treg cells in patients with rheumatoid arthritis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010, 26:267-272.
24. Esenten J.H., Wofsy J.A. Bluestone, Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat. Rev. Rheumatol. 2009, 5:560-565.
25. Schrier D.J., Schimmer R.C., Flory C.M., Tung D.K., Ward P.A. Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls. J. Leukocyte Biol. 1998, 63:359-363.
26. Ahmad S.F., Khan B., Bani S., Suri K.A., Satti N.K., Qazi G.N. Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production. Pharmacol. Res. 2006, 53:233-240.
27. Ahmad S.F., Zoheir K.M., Abdel-Hamied H.E., Ashour A.E., Bakheet S.A., Attia S.M., Abd-Allah A.R. Grape seed proanthocyanidin extract has potent anti-arthritic effects on collagen-induced arthritis by modifying the T cell balance. Int. Immunopharmacol. 2013, 17(1):79-87.
28. Jagdish N.S., Awatef M., Zaini M.A. Comparison between plethysmometer and micrometer methods to measure acute paw oedema for screening anti-inflammatory activity in mice. Inflammopharmacology 2004, 12(1):89-94.
29. Benslay D.N., Bendele A.M. Development of a rapid screen for detecting and differentiating immunomodulatory vs anti-inflammatory compounds in rats. Agents Actions 1991, 34:254-256.
30. Rong G., Zhou Y., Xiong Y., Zhou L., Geng H. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin. Exp. Immunol. 2009, 156:217-225.
31. Wang W., Shao S., Jiao Z., Guo M., Xu H. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol. Int. 2012, 32:887-893.
32. Billingham M.E.J., Davie G.E. Experimental models of arthritis in animals as screening tests for drugs to treat arthritis in man. Handbook Exp. Pharmacol. 1979, 50(2):108-144.
33. Kanno S., Shouji A., Tomizawa A., Hiura T., Osana Y., Ujibe M., Obara Y., Nakahata N., Ishikawa M. Inhibitory effect of naringin on lipopolysaccharide-induced endotoxin shock in mice and nitric oxide production in RAW264.7 macrophages. Life Sci. 2006, 78:673-681.
34. Lee E.Y., Lee C.K., Lee K.U., Park J.Y., Cho K.J., Cho Y.S. Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol. Int. 2007, 27:225-233.
35. Jones R.S., Ward J.W. Adjuvant-induced polyarthritis in rats. Methods and Achievements in Experimental Pathology 1966, 607-638. S Karger, New York. E. Bajusz, G. Jasmin (Eds.).
36. Colpaert F.C., Meert T., Witte P., Schmitt P. Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat. Life Sci. 1982, 31:67-75.
37. Gao Q., Shan J., Di L., Jiang L., Xu H. Therapeutic effects of daphnetin on adjuvant-induced arthritic rats. J. Ethnopharmacol. 2008, 120:259-263.
38. Banerjee S., Webber C., Poole A.R. The induction of arthritis in mice by the cartilage roteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell Immunol. 1992, 144:347-357.
39. Panayi G.S., Tugwell P. The use of cyclosporin A in rheumatoid arthritis: conclusions of an international review. Br. J. Rheumatol. 1994, 33:967-969.
40. Cao D., Rvan Vollenhoven, Klareskog L., Trollmo C., Malmstrom V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 2004, 6:R335-R346.
41. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
42. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 2004, 200:277-285.
43. Nocentini G. A multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol. 2005, 35(4):1016-1022.
44. Shevach E.M., Stephens G.L. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?. Nat. Rev. Immunol. 2006, 6(8):613-618.
45. Ji H.B., Liao G., Faubion W.A., Abadia-Molina A.C., Cozzo C., Laroux F.S., Caton A., Terhorst C. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J. Immunol. 2004, 172:5823-5827.
46. Stephens G.L., McHugh R.S., Whitters M.J., Young D.A., Luxenberg D., Carreno B.M., Collins M., Shevach E.M. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J. Immunol. 2004, 173:5008-5020.
47. Choy E.H., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl. J. Med. 2001, 344(12):907-916.
48. Borzi R.M., Mazzetti I., Macor S., Silvestri T., Bassi A., Cattini L. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett. 1999, 455(3):238-242.
49. Ogata H., Takeya M., Yoshimura T., Takagi K., Takahashi K. The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J. Pathol. 1997, 182(1):106-114.
50. Kunkel S.L., Lukacs N., Kasama T., Strieter R.M. The role of chemokines in inammatory joint disease. J. Leukoc. Biol. 1996, 59:6-12.
51. Kirkham B.W., Lassere M.N., Edmonds J.P., Juhasz K.M., Bird P.A., Lee C.S., Shnier R., Portek I.J. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 2006, 54:1122-1131.
52. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., van den Berg W.B. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004, 50:650-659.
53. Yeh L., Augustine A.J., Lee P., Riviere L.R., Sheldon A. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J. Rheumatol. 1995, 22:1740-1746.